Annual Drug Patent Expirations for VIMPAT
Vimpat is a drug marketed by Ucb Inc and is included in three NDAs. It is available from three suppliers. There is one patent protecting this drug and three Paragraph IV challenges.
Drug patent litigation for VIMPAT.
This drug has nineteen patent family members in eleven countries.
The generic ingredient in VIMPAT is lacosamide. Three suppliers are listed for this compound. Additional details are available on the lacosamide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
